₯2008”N

Asian Workshop for Hematopoietic Stem Cell Transplantation 2008

Date: January 18-20, 2008
Location: Kobe International Conference Center

Program:

Friday, January 18, 2008
œ
Registration
œ
Opening Remarks:
Dr. Hidehiko Saito (Nagoya Medical Center, Japan)
œ
Session 1: Transplantation for Nonmalignant Disease and Cellular Therapy
Chaired by Dr. Takanori Teshima (Kyushu University, Japan)
Keynote Lecture:
Cell Therapy For Non-Malignant Indications And Regenerative Medicine
    Dr. Shimon Slavin (Tel Aviv (Sourasky) Medical Center, Israel)
1) Prospective Multicenter Trial Comparing Alternative HSCT
@ With Second Immunosuppressants For Refractory Aplastic Anemia
Dr. Yoshiyuki Takahashi (Nagoya University Hospital, Japan)
2) Donor Cell Aplastic Anemia As A Cause Of Late Graft Failure
@ After Allogeneic HSCT
Dr. Shinji Nakao (Kanazawa University, Japan)
3) Immunoregulatory Potential of Allogeneic Mixed Chimerism
@ For Autoimmune Disease
Dr. Seok-Goo Cho
(St. Maryfs Hospital, Catholic University of Korea, Korea)
 
œ
Reception
 
Saturday, January 19, 2008
œ
Session 2: Infectious Complications
Chaired by Dr. Shinichiro Mori (National Cancer Center Hospital, Japan)
1) Hepatitis B Viral Infection In Hematopoietic Stem Cell Transplantation And Its @ @ Management in Taiwan
Dr. Tzeon-Jye Chiou (Taipei Veterans General Hospital, Taiwan)
2) Human Herpesvirus 6 Infection In Stem Cell Transplant Recipients
Dr. Masao Ogata (Oita University Hospital, Japan)
3) Reappraisal of Gastrointestinal Decontamination As A Routine Clinical Practice @ In Hematology/ Oncology Units
Dr. Tatsuo Ichinohe (Kyoto University Hospital, Japan)
 
œ
Walking Tour to Kobe Medical Industry Cluster Bases
   
œ
Session 3: Hematopoietic Stem Cell Transplantation from Alternative Donors
    Chaired by Dr. Makoto Murata (Nagoya University Hospital, Japan)
  Keynote Lecture: UR-BMT/PBSCT Using Reduced Intensity Preconditioning
    Dr. Sergio A. Giralt
(The University of Texas, M. D. Anderson Cancer Center, USA)
  1) High-Risk HLA Allele Mismatch Combinations Responsible
@ For Severe Acute GVHD And Implication For Its Molecular Mechanism
    Dr. Takakazu Kawase (Aichi Cancer Center Research Institute, Japan)
  2) Chronic GVHD After UR-BMT In Japan: Incidence, Risk Factors, And @ @Association With Relapse
    Dr. Chiaki Nakaseko (Chiba University Hospital, Japan)
  3) CBT For Hematological Malignancies
Dr. Naoyuki Uchida (Toranomon Hospital, Japan)

4) Unmanipulated HLA 2-3 Antigen-Mismatched (Haploidentical)
@Transplantation Using Myeloablative (Haplo-Full) And Reduced Intensity
@(Haplo-Mini) Conditioning

Dr. Kazuhiro Ikegame (Hyogo College of Medicine, Japan)
5) The Role Of Allo- Or Auto Stem Cells Transplantations Followed By @Immunorecovery In The Treatment Of Metastatic Breast Cancer Patients
Dr. Jun Ren (Peking University School of Oncology, China)
Sunday, January 22, 2008
œ
Session 4: Chronic GVHD
Chaired by Dr.Shinichiro Okamoto (Keio University, Japan) and
@@@@@@@ Dr. Paul Martin
@@@@@@@(Fred Hutchinson Cancer Research Center, USA)
Keynote Lecture: Diagnosis and Staging Of Chronic GVHD: Review
@@@@@@@@@@@And Critique Of the NIH Consensus Recommendations
    Dr. Paul Martin (Fred Hutchinson Cancer Research Center, USA)
1) Diagnosis And Staging Of Chronic GVHD: Korean Perspective
Dr. Chang-Ki Min (St. Maryfs Hospital, Catholic University of Korea, Korea)
2) Clinical Impact of Chronic GVHD On Japanese Patients
Dr. Yoshiko Atsuta (Nagoya University, Japan)
3) Supportive Cares For Chronic GVHD Focusing On Eye GVHD
Dr. Yoko Ogawa/ Dr. Shinichiro Okamoto
(Keio University Hospital, Japan)
œ

Closing Remarks:

Dr. Yoichi Takaue (National Cancer Center Hospital, Japan)

 

₯2006”N

Challenge for Current Problems and Future Direction
2nd iwNST Japan

Date: January 20-22, 2006
Location: Kazusa Academia Park

Program:

Friday, January 20, 2006
œ
Registration & Reception
Saturday, January21, 2006
œ
Opening Remarks:
Dr. Hidehiko Saito (Nagoya Medical Center, Japan)
œ
Workshop Topic 1: Overview of NST/RIST
Chaired by Dr. Mine Harada (Kyushu University, Japan)
1)Clinical Overview Worldwide RIST for Lymphoid Malignancies
Dr. Sergio Giralt (MD Anderson Cancer Center, USA)
2) Prospect of Clinical Activities and Scientific Research
Dr. Shimon Slavin (Hadassah University Hospital, Israel)
3) Overview of Fred Hutchinson Program for NST
Dr. Brenda Sandmaier (Fred Hutchinson Cancer Research Center, USA)
4) Japanese Overview of RIST
Dr. Takahiro Fukuda (National Cancer Center Hospital, Japan)
5) Korean Overview - Experiences of Asan Medical Center
Dr. Je-Hwan Lee (Asan Medical Center, University of Ulsan College of Medicine, Korea)
6) Overview of NST/RIST in China
Dr. Xiao-jun Huang (Institute of Hematology & People's Hospital, Peking University, China)
œ
Workshop Topic 2: GVHD and TMA
Chaired by Dr. Yoshihisa Kodera (Japanese Red Cross Nagoya First Hospital, Japan)
1) Microangiopathy and GVHD
Dr. Takanori Teshima (Kyushu University Hospital, Japan)
2) Pathology of GVHD
Dr. George E. Sale (University of Washington and Fred Hutchinson Cancer Research Center, USA)
3) Steroid Refractory GVHD
Dr. Sergio Giralt (MD Anderson Cancer Center, USA)
4) Acute GVHD in Japan
Dr. Yoshihisa Morishita (Syowa Hospital Aichi Prefectural Welfare Federation of Agricultural Cooperatives, Japan)
5) TMA (Case Presentation)
Dr. Taku Ohba (Japanese Red Cross Nagoya First Hospital, Japan)
6) Pathology of TMA
Dr. Masafumi Ito (Japanese Red Cross Nagoya First Hospital, Japan)
Sunday, January 22, 2006
œ
Workshop Topic 3: New Dimension of Non-myeloablative Stem Cell Transplantation
Chaired by Dr. Shuichi Taniguchi (Toranomon Hospital, Japan)
1) Cord Blood Transplantation: Clinical Analysis of Toranomonfs Data
Dr. Shuichi Taniguchi (Toranomon Hospital, Japan)
2) Overview of RIST for Solid Tumors
Dr. Yoshinobu Kanda (University of Tokyo Hospital, Japan)
3) Immunotherapeutic Approach (T-reg Control) from the Aspect of Basic Research
Dr. Yuji Heike (National Cancer Center Research Institute, Japan)
œ

Closing Remarks:

Dr. Yoichi Takaue (National Cancer Center Hospital, Japan)

 

₯2004”N

1st iwNST Japan

Date:February 20-22, 2004
Location:Hotel New Akao, gRoyal Wingh, Atami, Shizuoka, Japan

Program:

Friday, February 20
œ
Registration & Reception
Saturday, February 21
œ
Opening Remarks:
Hidehiko Saito, Nagoya National Hospital
Chairman of iwNST Japan Committee
œ
Topic 1:Clinical Management of GVHD in NST
Chaired by
Mine Harada, Kyushu University
Emma Morris, Royal Free and University College, Hospital Medical School London, UK
Review Presentation
1) Current Art & Issue in Japan
Takanori Teshima, Okayama University
2) Current Art & Issue in the USA & European Countries
Emma Morris, Royal Free and University College, Hospital Medical School London, UK
3) Proposal of Future Clinical Program: Suitable Prophylaxis Regimen for GVHD
Shinichiro Mori, National Cancer Center Hospital
œ
Topic 2:Conditioning Regimens for Leukemia and Malignant Lymphoma
Chaired by
Shuichi Taniguchi, Toranomon Hospital
Sergio Giralt, MD Anderson CC, USA
Review presentation
1) Current Art & Issue in Japan
Koichi Miyamura, Japanese Red Cross Nagoya Hospital First
2) Current Art & Issue in the USA & European Countries
Sergio Giralt, MD Anderson CC, USA
3) Proposal of Future Clinical Program Establishing Individualized Regimens
Takahiro Fukuda, Kyushu University
œ
Topic 3:Expansion of Stem Cell Source (Cord Blood Transplantation)
Chaired by
Hidehiko Saito, Nagoya National Hospital
John E. Wagner, University of Minnesota, USA
Review presentation
1) Current Art & Issue in Japan
Shigesaburo Miyakoshi, Toranomon Hospital
2) Current Art & Issue in the USA & European Countries
John E. Wagner, University of Minesota, USA

3) Research Requirements in Cord Blood Stem Cell Transplantation

Yuji Heike, National Cancer Center Research Institute
œ
Topic 4:NST for Non-Hematological Disorders (Solid Tumors and Non-Malignant Diseases)
Chaired by
Masahiro Imamura, Hokkaido University
Richard Burt, Northwestern University, USA
Review presentation
1) Current Art & Issue in Japan
Kouji Nagafuji, Kyushu University
2) NST for Non-Hematological Disorders (Autoimmune Diseases)
Richard Burt, Northwestern University, USA
3) Proposal of Future Clinical Program: Potential of NST for Non-Hematological Disorders
Masahiro Kami, National Cancer Center Hospital
Sunday, February 22
œ

Topic 5: Strategy for HLA-Mismatched Transplantation (Haplo-Identical Transplantation and CD34 Positive Cell Selection)

Chaired by
Yoichi Takaue, National Cancer Center Hospital
David A. Rizzieri, Duke University Medical Center
Review presentation
1) Current Art & Issue in Japan
Tatsuo Ichinohe, Kyoto University
2) Current Art & Issue in the USA & European Countries
David A. Rizzieri, Duke University
3) Proposal of Future Clinical Program: Potential of unmanipulated HLA-mismatched transplantation
Yoshinobu Kanda, Tokyo University
œ
Lecture: Supporting System for Investigator-Initiated Studies / Trials in Japan
Chaired by
Yoichi Takaue, National Cancer Center Hospital
Lectured by
Yasuo Ohashi, Japan Clinical Research Support Unit (University of Tokyo)
œ
Overall Summary
Chaired by
Yasuo Ohashi, Japan Clinical Research Support Unit (Tokyo University)
œ
Closing Remarks:
Yoichi Takaue, National Cancer Center Hospital
Executive Committee Member of iwNST Japan